Welcome to LookChem.com Sign In|Join Free

CAS

  • or

72087-37-7

Post Buying Request

72087-37-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72087-37-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 72087-37-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,0,8 and 7 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 72087-37:
(7*7)+(6*2)+(5*0)+(4*8)+(3*7)+(2*3)+(1*7)=127
127 % 10 = 7
So 72087-37-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H10O3.C5H12N2O2/c1-4(2)3-5(7)6(8)9;6-3-1-2-4(7)5(8)9/h4H,3H2,1-2H3,(H,8,9);4H,1-3,6-7H2,(H,8,9)/t;4-/m.0/s1

72087-37-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2,5-diaminopentanoic acid,4-methyl-2-oxopentanoic acid

1.2 Other means of identification

Product number -
Other names L-Ornithine,mono(4-methyl-2-oxopentanoate)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72087-37-7 SDS

72087-37-7Upstream product

72087-37-7Downstream Products

72087-37-7Relevant articles and documents

Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

-

, (2008/06/13)

Novel compounds are prepared by reacting ornithine or arginine with alpha keto analogs of branched chain essential amino acids, namely valine, leucine and isoleucine. The compounds are useful either individually or as a mixture in the treatment of hepatic disorders which are characterized by hyperammonemia and portal systemic encephalopathy. Use of these compounds in treatment of renal failure also appears promising.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 72087-37-7